All About: Prescription Drugs Submitted by ruzik_tuzik on Jul 4th, 2009 The FDA notified the public that the use of two prescription medicines used to help smoking cessation, Chantix (varenicline) manufactured by Pfizer Inc or Zyban(bupropionhydrochloride) manufactured by GlaxoSmithKline, has been associated with reports of behavior changes including hostility, agitation, depressed mood, and suicidal thoughts or actions. The FDA is requiring the manufacturers of these products, including generic versions of Zyban (bupropion), to add a new Boxed Warning to the product labeling to alert healthcare professionals to this important new safety information. The new precautions being recommended include: People who are taking Chantix or Zyban and experience any serious and unusual changes in mood or behavior or who feel like hurting...
[read full story]
powered by 